Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy.
Open Access
- 1 February 1994
- journal article
- case report
- Published by BMJ in Archives of Disease in Childhood
- Vol. 70 (2) , 136-138
- https://doi.org/10.1136/adc.70.2.136
Abstract
Three children who developed pulmonary aspergillosis while being treated for leukaemia or non-Hodgkin's lymphoma. Each child continued with intensive myelosuppressive chemotherapy regimens during the infection and each was successfully treated with antifungal prophylaxis based on itraconazole by mouth. Amphotericin B was also given during periods of severe neutropenia. No reactivation of the fungal infection was seen.Keywords
This publication has 16 references indexed in Scilit:
- Antifungal Prophylaxis in Bone Marrow TransplantationClinical Infectious Diseases, 1990
- Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma LevelsMycoses, 1989
- An approach to intensive antileukemia therapy in patients with previous invasive aspergillosisThe American Journal of Medicine, 1988
- Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapyThe American Journal of Medicine, 1988
- Oral Treatment of Paracoccidioidomycosis and Histoplasmosis with Itraconazole in HumansClinical Infectious Diseases, 1987
- Itraconazole in the Treatment of Human Mycoses: Review of Three Years of Clinical ExperienceClinical Infectious Diseases, 1987
- Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized StudiesClinical Infectious Diseases, 1987
- Problems of infection after bone marrow transplantation.Journal of Clinical Pathology, 1983
- Fungal infections in patients with acute leukemiaThe American Journal of Medicine, 1982
- Protective Environment for Marrow Transplant RecipientsAnnals of Internal Medicine, 1978